Programme: Tuesday, 14 November

08:00 – 11:00 | 243

Workshop: A Holistic Approach to Planning for a Digital Adherence Technology Intervention

Rachel Powers: Developing Differentiated Care Pathways

08:00 – 11:00 | 252AB

Workshop: Lessons learned from the multi-country BPaL introduction and ways forward to the programmatic scale-up

Agnes Gebhard: Chair

Mansa Mbenga: BPaL programmatic scale-up: Lessons Learned from BPaL implementation: considerations for developing a roadmap for the programmatic scale-up.

Veriko Mirtskhulava: Programmatic scale-up of BPaL/M Regimen: Monitoring end Evaluation Framework.

14:30 – 17:30 | 241

Workshop: Joint GLI-GDI Workshop: using BPaL/M, diagnostic and treatment aspects

Maria Imelda Quelapio: BPaL: Field experience in the Philippines under operational research

14:30 – 17:30 | 252AB

Workshop: Introduction and scale up of stool-based testing– sharing country results and practical lesson learned

Chair: Petra de Haas

14:30 – 17:30 | 253

Workshop: An economic model that shows the saving potential and budget impact for countries when using BPaLM/BPaL instead of standard regimens

Maria Imelda Quelapio: Clinical aspects of the BPaLM/BPaL regimens and cost considerations

Programme: Wednesday, 15 November

10:15 – 11:45 | 242 B

Short Oral Abstract Session: Treatment and treatment outcomes of DR – TB

Maria Imelda Quelapio: Modifications on the BPaL regimen in under operational research in the Philippines

13:00 – 15:00 | Salle Maillot 5

TBScience E-Poster Session: Moderated E-Poster Session

Veriko Mirtskhulava: Antimicrobial resistance stewardship: lessons learned from drug-resistant tuberculosis programs – a scoping review

15:00 – 16:30 | 221M + 222

Oral Abstract Session: Safety of regimens for R-R

Veriko Mirtskhulava: Safety and effectiveness of the BPaL regimen: preliminary analysis of the first multi-country operational research cohort

15:00 – 16:30 | 231M + 232M

Short Oral Abstract Session: Access to quality TB care and services

Omotayo Salau: Strategic initiative to find people with tuberculosis (TB) among hospital attendees: unprecedented efforts to detect and notify additional TB cases in North Central, Nigeria

15:00 – 16:30 | 242 B

Short Oral Abstract Session: Diagnostics, including drug-resistance determination: Technical aspects and new developments

Chair: Kristin Kremer

15:00 – 16:30 | 252AB

Special session: The WHO’s new evidence-based guidelines on TB – how we can transform practice to accelerate TB eradication

Agnes Gebhard: Moderated panel discussion with Q&A

16:45 – 18:15 | 231M + 232M

Oral Abstract Session: How media can shape the message

Onyinye Kene-Eheh: Incentives as an effective TB communication tool: a case study of KNCV Nigeria’s Facebook page

16:45 – 18:15 | 253

Oral Abstract Session: Finding the missing children with TB

Ogoamaka Chukwuogo: Reversing the trend of low childhood TB diagnosis in Nigeria: the usefulness of stool-based Xpert testing

18:30 – 20:00 | 242B

Satellite Session: Digital adherence technologies in TB care: key results and lessons from the Adherence Support Coalition to End TB (ASCENT) trial

Chair: Kristian van Kalmthout

Adrian Leung: Process evaluation of ASCENT trials

Degu Dare: Key learnings from the ASCENT journey to enhance TB treatment outcomes through digital adherence technologies

Programme: Thursday, 16 November

08:30 – 10:00 | 202/203

Oral Abstract Session: Key Populations

Chair: Christiaan Mulder

08:30 – 10:00 | 221M + 222

Oral Abstract Session: CAD for Tuberculosis

Sani Useni: An analysis of the impact of portable digital X-ray on TB screening in hard-to-reach communities in Nigeria

Mustapha Tukur: Use of artificial intelligence to analyse chest X-rays for TB: Results from pilot studies of two independent softwares

08:30 – 10:00 | 252AB

Short Oral Abstract Session: Integrated services for TB case finding

Kenneth Ekpen: Improving TB case-finding through community interventions using the Wellness-on-Keke Model in Nigeria

10:15 – 11:45 | 242B

Oral Abstract Session: Strategies to improve active case finding

Chidubem Ogbudebe: Improving TB detection through targeted active TB screening using a peer-network hub strategy in Nigeria

Ogoamaka Chukwuogo: Systematic screening for TB disease using a combination of the WHO 4-symptom screening and chest X-ray with computer-aided detection in identified TB hotspot communities in Nigeria

15:00 – 16:30 | 202/203

Oral Abstract Session: Lessons learnt from the use of new technologies for TB prevention and care

Doris Ekpo: Programme benefits of using a localised performance tracker at the start of a project: TB-HIV integrated services in Lagos State, Nigeria

Ezinne Nwokoro: Lessons learnt from the SMS/USSD project implementation in Nigeria: the KNCV TB LON Regions 1 and 2 experience

15:00 – 16:30 | 252AB

Symposium: Urgent need for coordinated action to accelerate TB vaccine access

Chair: Joeri Buis

15:00 – 16:30 | 241

Oral Abstract Session: Validation of Diagnostics

Joseph Omame: Integrated TB and COVID-19 community intervention, a tool for improved TB case detection and COVID-19 vaccine uptake – the Bauchi state experience

15:00 – 16:30 | 253

Oral Abstract Session: Breaking down silos: Bidirectional TB and COVID screening

Chinenye Igwetu: Reducing missed opportunities in strengthening TB awareness in communities: leveraging COVID-19 vaccination campaigns in Taraba State, Nigeria

Aminu Babayi: Leveraging active TB case-finding using the Wellness-on-Keke intervention in the community to improve COVID-19 vaccine uptake in Nigeria

Degu Dare: Bi-directional screening strategies for TB and COVID-19 in Nigeria and the Philippines: case studies of two best practices

16:45 – 18:15 | 251

Oral Abstract Session: Models of Active Case Finding and Contact Investigation

Lotanna Ugochukwu: Strengthening intensified case-finding in public facilities without diagnostic tools using the healthcare worker model: an experience from Kano State, Nigeria

Yekumah Wali: Strategic integration of active TB case-finding into the COVID-19 vaccination programme – experience from the KNCV Nigeria GLOVAX Project in Anambra and Imo State, Nigeria

Programme: Friday, 17 November

07:15 – 08:15 | 252AB

Symposium: TB diagnostics, including drug-resistance determination – Technical aspects and new developments

Justin O’Grady (Oxford Nanopore Technologies): Chair

Kristin Kremer: The Dream Fund project on nanopore sequencing for tuberculosis and other infectious diseases in low- and middle-income countries; first experiences from Kyrgyzstan

08:30 – 10:00 | 243

Symposium: Challenging the use of digital technologies for TB diagnosis: global vision and experiences from Ethiopia, Nigeria, Vietnam and the Latin American and Caribbean region

Degu Dare: Chair

Sani Useni: Portable digital X-ray with AI to strengthen TB case-finding among key populations in Nigeria: an innovative public-private partnership scale-up model

10:15 – 11:45 | 242 A

Oral Abstract Session: TB: How much does it cost?

Dawit Getachew Assefa: Costs faced by TB patients in Ethiopia: a systematic review and meta-analysis

10:15 – 11:45 | 243

Symposium: Reaching agreement on the inclusion of pregnant and lactating persons in TB research

Mansa Mbenga: Chair

10:15 – 11:45 | 251

Symposium: Multi-testing for TB and other diseases with WHO-recommended rapid molecular diagnostics and clinical monitoring: perspectives from high TB burden settings

Jerod N. Scholten: Chair

Endale Mengesha: Multi-disease testing using GeneXpert® equipment:  The Ethiopian experience

Carel Joseph: Molecular Multi disease testing platform till the periphery with WHO endorsed Rapid molecular testing (TrueNAAT) – fully domestic funded initiative from India

Fehinti Prisca Ajiboye: Implementation of multi-testing on the GeneXpert platform across Nigeria

15:00 – 16:30 | Amphitheatre Bleu

Symposium: The impact of digital adherence technologies on TB care: Results from ASCENT and other studies

Kristian van Kalmthout: Chair

Degu Dare: Effectiveness of digital adherence technologies in improving TB treatment: interim results from the ASCENT studies

15:00 – 16:30 | 202/203

Short Oral Abstract Session: Imaging for a TB free world

Mathew Fila: Portable digital X-ray and dynamics in active TB case-finding

Yekumah Wali: Concordance rate of expert reviews of PDX-CAD radiograph and molecular WHO-recommended rapid diagnostics for TB active case-finding in Delta State, Nigeria

15:00 – 16:30 | 242 B

Oral Abstract Session: Finding TB cases among vulnerable populations

Chidubem Ogdudebe: Evaluating the efficiency of active case-finding interventions to improve childhood TB in Nigeria

Ogoamaka Chukwuogo: Yield from active TB case-finding activities in prisons: implications for routine TB screening in Nigerian penitentiary institutions

15:00 – 16:30 | 243

Symposium: Closing the gaps in paediatric TB – expediting TB diagnosis in children to reach High-Level Meeting targets

Edine Tiemersma: Chair

16:45 – 18:15 | 231M + 232M

Oral Abstract Session: Digital methodologies in TB prevention and care

Chidubem Ogdudebe: The impact of hot-spot mapping on TB yield from community case-finding interventions: Experience from Nigeria

16:45 – 18:15 | 243

Short Oral Abstract Session: Global and local policies to Improve TB care and services

Degu Dare: Engaging key stakeholders from high-priority countries for strengthening research capacity to end TB: results from global stakeholder survey

Amina Kewa: Leveraging TB public health messaging to drive vaccination demand in local communities

16:45 – 18:15 | 253

Oral Abstract Session: Rapid tests for all TB cases

Endale Mengesha: High TB case notification through improved use of GeneXpert testing in Ethiopia

Ogoamaka Chukwuogo: Improving efficiency of the TB screening cascade: utility of a one-stop shop for TB diagnosis in the community

18:30 – 20:00 | 242 B

Satellite Session: Transforming evidence into practice – celebrating 120 years experience as inspiration for the future

Chairs: Kitty van Weezenbeek & Chakaya Muhwa

Maarten van Cleeff: The changing role of INGO’s in ending TB: Best practices from KNCV Tuberculosis Foundation

Mustapha Gidado: KNCV transformation from a national Dutch NGO to international network for elimination of TB

Agnes Gebhard: Innovation pathways: innovation – demonstration – scale-up

Kristin Kremer: Transforming the diagnostic landscape

Bethrand Odume: KNCV TB FOUNDATION NIGERIA – the journey to self-reliance

Programme: Saturday, 18 November

08:30 – 10:00 | 231M+232M

Satellite Session: TB diagnosis by molecular lens

Shalom Balogun: Lateral-flow urine lipoarabinomannan test for TB diagnosis in people living with HIV in Nigeria: a case study from the states of Benue and Taraba

08:30 – 10:00 | 241

Oral Abstract Session: TB Diagnosis for all and MWD for all

Nkiru Nwokoye: Impact of using WHO-recommended rapid molecular diagnostics in a mobile fashion for community active case-finding interventions: the KNCV Nigeria experience

08:30 – 10:00 | 252

Oral Abstract Session: Progress in TB case finding

Stephanie Gande: Evaluation of active TB case-finding among special populations in Bauchi State, Nigeria

10:15 – 11:45 | 243

Oral Abstract Session: Improving TB Diagnosis and Care

Yekumah Wali: The role of artificial intelligence in community active TB case-finding: a review of portable digital X-ray with computer-aided detection activities in Delta State, Nigeria

Husna Baffa: Is public-private mix the way to end the TB epidemic? A case study of patent medicine vendors in five high-burden local government areas in Kano, Nigeria


  • Experiences and lessons learnt in piloting stool Xpert testing in children in Kinshasa, DR Congo
  • TrueNat, an effective diagnostic tool for detecting drug-resistant TB: A case study from the TB LON 1 and 2 Projects
    Presenter Chineye Igwetu
  • Point-of-care programme in HIV, TB and associated conditions: A strategic global virtual initiative
    Presenter: Degu Dare
  • Four years of pharmacovigilance strengthening for drug-resistant TB in Eswatini, Ethiopia, Nigeria and Tanzania: Results from the PhArmacoVIgilance in Africa (PAVIA) project
    Presenter: Edine Tiemersma
  • Optimising private sector TB prevention and care through the strategic engagement of private laboratories: The TB LON experience in Akwa-Ibom and Kano States, Nigeria
    Presenter: Michael Sheshi
  • Spot to tent – using a systematic approach to contact investigation in Kano State, Nigeria
    Presenter: Husna baffa
  • Patient and provider acceptability of digital adherence technologies for TB treatment in Ethiopia
  • A new, versatile and open-source mathematical modelling framework applied to estimating the impact of novel TB vaccines
  • Uptake of TB preventive therapy (3HR): experiences from Akwa Ibom, Cross River and River States, Nigeria
    Presenter: Ifiok Ekanim
  • The Automated Partners Progress Report: Strengthening data-driven approach to TB case notification in Nigeria
  • Cutaneous lesions of patients treated with BPaL in the Philippines under operational research
  • Improving TB case-finding using optimised TB screening strategy among at-risk populations in Nigeria
    Presenter: Sani Useni
  • Improving portable digital X-ray-driven active TB case-finding using the X-MAP system in Nigeria
    Presenter: Kenneth Ekpen
  • Designing a TB elimination framework through participatory processes in Ethiopia: results from stakeholders’ discussions

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi


De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.